Antiretroviral Market Research Report Forecast (2013-2023)

Date: 5 April 2019

Over the recent years, Antiretroviral Market has been witnessing growth on account of several driving factors including growing prevalence of HIV AIDS, growing antiretroviral treatment coverage rate, and increase in availability of novel drugs with better efficacy. Moreover, factors such as growing medical spending, favorable steps by government of various countries, decreased cost of treatment, improved diagnosis rate, and rise in the favorable programs to provide diagnosis and treatment facilities to the unmet patient population has been driving the market growth of antiretroviral drugs. In addition, increasing uptake of INSTI based regimens, increasing awareness regarding HIV care and treatment procedures, new drug launches, and improved R&D pipeline are anticipated to fuel the market growth in forecasted period. However, growing portfolio of generic antiretroviral drugs is expected impact the overall market growth.

What are the major Antiretroviral segments covered in the Azoth Analytics report?

The major Antiretroviral segments covered in the report include Multi-Class Drugs Combination Drugs, NRTI, NNRTI, Protease Inhibitors, and Others.

What are the regions and countries covered in the study on Antiretroviral market?

The regional markets covered in the report include North America, Europe, Asia Pacific, Rest of the World.

The countries analyzed in the report include U.S., Canada, Germany, U.K, France, Italy, China, Japan, India, and South Africa

Name the companies profiled in the report?

The companies profiled in the report include Gilead Sciences Inc., ViiV Healthcare, Bristol-Myers Squibb, AbbVie Inc., Boehringer Ingelheim, Johnson & Johnson, Merck & Co., Cipla, Mylan

What are the key factors driving the market of Antiretroviral?

·         Rising HIV Prevalence.

·         Increased Awareness